171 related articles for article (PubMed ID: 35715770)
1. Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma.
Zhou G; Zhang S; Jin M; Hu S
BMC Cancer; 2022 Jun; 22(1):667. PubMed ID: 35715770
[TBL] [Abstract][Full Text] [Related]
2. Key modules and hub genes identified by coexpression network analysis for revealing novel biomarkers for larynx squamous cell carcinoma.
Zhang H; Zhao X; Wang M; Ji W
J Cell Biochem; 2019 Dec; 120(12):19832-19840. PubMed ID: 31310372
[TBL] [Abstract][Full Text] [Related]
3. Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry.
Li JD; Chen Y; Jing SW; Wang LT; Zhou YH; Liu ZS; Song C; Li DZ; Wang HQ; Huang ZG; Dang YW; Chen G; Luo JY
Eur J Med Res; 2023 Dec; 28(1):591. PubMed ID: 38102653
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of zinc finger protein 71 in laryngeal squamous cell carcinoma tissues and its potential molecular mechanism and clinical significance: a study based on immunohistochemistry staining and data mining.
Jiang FC; Luo JY; Dang YW; Lu HP; Li DM; Huang ZG; Tang YL; Fang YY; Tang YX; Su YS; Dai WB; Pan SL; Feng ZB; Chen G; He J
World J Surg Oncol; 2022 Nov; 20(1):359. PubMed ID: 36369089
[TBL] [Abstract][Full Text] [Related]
5. The matrix metalloproteinase gene family: a significant prognostic gene lineage correlated with immune infiltrates in laryngeal squamous cell carcinoma.
Yang C; Cao H; Yang JW; Liu T; Wang JT; Wang BS
Neoplasma; 2021 Nov; 68(6):1212-1224. PubMed ID: 34585589
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of transcription factor WD repeat and HMG-box DNA binding protein 1 in laryngeal squamous cell carcinoma and its potential molecular mechanism.
Wu JY; Lan XL; Yan DM; Fang YY; Peng YX; Liang FF; Jiang L; Huang SN; Mo M; Lin CX; Niu YT; Wu XW; Wei ZX
Pathol Res Pract; 2022 Feb; 230():153751. PubMed ID: 34999279
[TBL] [Abstract][Full Text] [Related]
7. Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.
Karamagkiolas S; Giotakis I; Kyrodimos E; Giotakis EI; Kataki A; Karagianni F; Lazaris AM
Am J Otolaryngol; 2019; 40(4):487-493. PubMed ID: 30979652
[TBL] [Abstract][Full Text] [Related]
8. Cell Cycle-Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer.
Chen J; Luo J; He J; Jiang X; Jiang N; Yang C; Zhong S
Biomed Res Int; 2023; 2023():1733100. PubMed ID: 36718148
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
[TBL] [Abstract][Full Text] [Related]
10. COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC.
Zhang J; Wang X; Li G; He J; Lu Z; Yang Y; Jiang Y; Jiang L; Li F; Liu J
Biomed Res Int; 2021; 2021():6648078. PubMed ID: 33824874
[TBL] [Abstract][Full Text] [Related]
11. SIRT4 expression in laryngeal squamous cell carcinoma.
Wan W; Li Y; Zhou C; Sun B; Yang S; Zhou C
Pharmazie; 2020 Dec; 75(12):646-650. PubMed ID: 33303058
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological value of hematopoietic cell kinase overexpression in laryngeal squamous cell carcinoma tissues.
Xia S; Li JD; Yan SB; Huang ZG; Liu ZS; Jing SW; Li DZ; Song C; Chen Y; Wang LT; Zhou YH; Huang R; Shi N; Lan SY; Chen G; Fan XH
Pathol Res Pract; 2023 Jul; 247():154534. PubMed ID: 37201466
[TBL] [Abstract][Full Text] [Related]
14. A preliminary analysis of prognostic genes in advanced laryngeal squamous cell carcinoma patients with postoperative radiotherapy.
Hu C; Lao Z; Yan L; Song X; Wang J
Pathol Res Pract; 2023 Jan; 241():154229. PubMed ID: 36509010
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
Li Y; Xu J; Guo YN; Yang BB
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
[TBL] [Abstract][Full Text] [Related]
17. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
Qian L; Ni T; Fei B; Sun H; Ni H
BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824
[TBL] [Abstract][Full Text] [Related]
18. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
19. Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes.
Liu Y; Liu N; Zhou X; Zhao L; Wei W; Hu J; Luo Z
Front Endocrinol (Lausanne); 2023; 14():1245629. PubMed ID: 37876534
[TBL] [Abstract][Full Text] [Related]
20. A combination of mRNA expression profile and miRNA expression profile identifies detection biomarkers in different tumor stages of laryngeal squamous cell carcinoma.
Yu CH; Xing FY; Zhang JY; Xu JQ; Li YC
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7296-7304. PubMed ID: 30468474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
